HT
KYNB

HAP Trading’s Kyntra Bio KYNB Stock Holding History

HAP Trading’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-840
Closed -$7K – 2074
2020
Q4 		$7K Buy
+840
New +$883K ﹤0.01% 1969
2020
Q1 		– Sell
-3,232
Closed -$188K – 1302
2019
Q4 		$188K Buy
3,232
+2,788
+628% +$2.85M 0.01% 465
2019
Q3 		$13K Sell
444
-432
-49% -$474K ﹤0.01% 1014
2019
Q2 		$123K Buy
+876
New +$959K 0.01% 564
2018
Q1 		– Sell
-524
Closed -$89K – 1009
2017
Q4 		$89K Sell
524
-56
-10% -$70.2K ﹤0.01% 601
2017
Q3 		$209K Buy
580
+12
+2% +$12.6K 0.01% 501
2017
Q2 		$64K Buy
568
+128
+29% +$89.2K ﹤0.01% 654
2017
Q1 		$34K Sell
440
-720
-62% -$438K ﹤0.01% 745
2016
Q4 		$38K Buy
1,160
+144
+14% +$71.9K ﹤0.01% 684
2016
Q3 		$51K Buy
+1,016
New +$479K ﹤0.01% 696
2016
Q2 		– Sell
-1,056
Closed -$49K – 956
2016
Q1 		$49K Buy
+1,056
New +$526K ﹤0.01% 530

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HAP Trading's KYNB Position: Q4 2021 in Review

HAP Trading sold out of Kyntra Bio (KYNB) in Q4 2021, closing a stake of 787 shares — an estimated $201K sold.

HAP Trading first reported a position in KYNB in Q2 2018 and held it in 5 quarters. The position peaked at $3.99M in Q2 2018. 162 funds tracked by Wall St. Rank hold KYNB as of Q4 2021.

  • HAP Trading reported no remaining Kyntra Bio position as of Q4 2021 after selling out during the quarter.
  • HAP Trading sold 787 Kyntra Bio shares in Q4 2021, an estimated $201K.
  • HAP Trading first reported a position in Kyntra Bio in Q2 2018 and held it in 5 quarters.
  • HAP Trading's Kyntra Bio position peaked at $3.99M in Q2 2018.
  • 162 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.